12-48000055-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001844.5(COL2A1):c.156C>A(p.Cys52*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C52C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001844.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IIInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Kniest dysplasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
- platyspondylic dysplasia, Torrance typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- spondyloepimetaphyseal dysplasia, Strudwick typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- spondyloepiphyseal dysplasia congenitaInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia with metatarsal shorteningInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spondyloperipheral dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Stickler syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Illumina, Orphanet, Genomics England PanelApp
- Stickler syndrome, type I, nonsyndromic ocularInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- avascular necrosis of femoral head, primary, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Legg-Calve-Perthes diseaseInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia, Stanescu typeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant rhegmatogenous retinal detachmentInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dysspondyloenchondromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial avascular necrosis of femoral headInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple epiphyseal dysplasia, Beighton typeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasia, Schmidt typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- otospondylomegaepiphyseal dysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- vitreoretinopathy with phalangeal epiphyseal dysplasiaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL2A1 | ENST00000380518.8 | c.156C>A | p.Cys52* | stop_gained | Exon 2 of 54 | 1 | NM_001844.5 | ENSP00000369889.3 | ||
COL2A1 | ENST00000337299.7 | c.86-1624C>A | intron_variant | Intron 1 of 52 | 1 | ENSP00000338213.6 | ||||
COL2A1 | ENST00000474996.6 | n.394C>A | non_coding_transcript_exon_variant | Exon 3 of 8 | 3 | |||||
COL2A1 | ENST00000490609.2 | n.389C>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Loss-of-function variants in COL2A1 are known to be pathogenic (PMID: 20179744). This sequence change creates a premature translational stop signal (p.Cys52*) in the COL2A1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with COL2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 547245). For these reasons, this variant has been classified as Pathogenic. -
Has not been previously published as pathogenic or benign to our knowledge; Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD) -
Inborn genetic diseases Pathogenic:1
The c.156C>A (p.C52*) alteration, located in exon 2 (coding exon 2) of the COL2A1 gene, consists of a C to A substitution at nucleotide position 156. This changes the amino acid from a cysteine (C) to a stop codon at amino acid position 52. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. -
COL2A1-related disorder Pathogenic:1
The COL2A1 c.156C>A variant is predicted to result in premature protein termination (p.Cys52*). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Nonsense variants in COL2A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Stickler syndrome type 1 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at